ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

APYX vs SKYA // 10Y YIELD & FRED MACRO BETA

Apyx Medical Corporation (NASDAQ) VS. SkyAI Inc. (NASDAQ) • 15-METRIC TALLY: APYX 6 — SKYA 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APYX VS. SKYA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC APYX SKYA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.50% -30.00% +92.50 APYX /gross-margins <GO>
Return on Invested Capital (ROIC) -28.90% -35.00% +6.10 APYX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.04% -8.67% +0.63 APYX /fcf-yield <GO>
Operating Margin -12.20% -60.00% +47.80 APYX /operating-margins <GO>
Net Profit Margin -21.20% -60.00% +38.80 APYX /net-margins <GO>
Revenue Growth (YoY) 9.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.75 11.30 -10.55 SKYA /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 APYX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.1 74.0 -24.85 SKYA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $113.3M $126.7M -$13.4M SKYA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR APYX REV SKYA REV APYX GROSS % SKYA GROSS % APYX FCF SKYA FCF
FY 2025 $52.8M $204.1K 62.5% -50.0% -$9.1M -$11.0M
FY 2024 $48.1M $0 61.0% — -$18.8M -$4.5M
FY 2023 $52.3M $0 — — -$5.2M -$8.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APYX // BETA —
SKYA // BETA —